Clovis Oncology to Announce Third Quarter 2012 Financial Results and Host Webcast Conference Call on November 5 Business Wire BOULDER, Colo. -- October 18, 2012 Clovis Oncology, Inc. (Nasdaq:CLVS) will announce its third quarter 2012 financial results on Monday, November 5, 2012, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast on Monday, November 5, at 4:30 p.m. ET to discuss the company’s results in greater detail. The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days. About Clovis Oncology Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK. Contact: Clovis Oncology, Inc. Anna Sussman, 303-625-5022 firstname.lastname@example.org or Breanna Burkart, 303-625-5023 email@example.com
Clovis Oncology to Announce Third Quarter 2012 Financial Results and Host Webcast Conference Call on November 5
Press spacebar to pause and continue. Press esc to stop.